Pharmaceutical Stocks Worth Watching - November 21st

Eli Lilly and Company logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Seven high-trading-volume pharmaceutical stocks highlighted are Eli Lilly, Johnson & Johnson, AbbVie, Merck, Gilead Sciences, Pfizer, and McKesson.
  • Friday trading was mixed: McKesson rose $7.15 and Johnson & Johnson gained $3.40, while Eli Lilly fell $4.72; Pfizer and Gilead also edged lower.
  • The companies span drug development and manufacturing as well as healthcare distribution, with portfolios covering areas such as diabetes, cancer, infectious diseases, and vaccines.
  • Five stocks we like better than Eli Lilly and Company.

Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck & Co., Inc., Gilead Sciences, Pfizer, and McKesson are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies that develop, manufacture, or sell medicines and related healthcare products. For investors, their value can be influenced by drug approvals, patent protections, clinical-trial results, regulation, and demand for treatments. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE:LLY traded down $4.72 during midday trading on Friday, reaching $1,346.40. 3,539,886 shares of the company's stock traded hands, compared to its average volume of 3,049,248. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.00 and a current ratio of 1.39. Eli Lilly and Company has a one year low of $850.51 and a one year high of $1,475.25. The company has a market cap of $1.27 trillion, a price-to-earnings ratio of 43.70, a P/E/G ratio of 1.71 and a beta of 0.40. The stock has a 50 day moving average of $1,268.06 and a 200 day moving average of $1,119.25.

Read Our Latest Research Report on LLY

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of NYSE JNJ traded up $3.40 during trading on Friday, reaching $270.54. 11,918,705 shares of the company traded hands, compared to its average volume of 7,422,689. The firm has a 50 day simple moving average of $267.53 and a 200-day simple moving average of $250.98. Johnson & Johnson has a 52-week low of $199.90 and a 52-week high of $290.25. The stock has a market capitalization of $651.27 billion, a PE ratio of 40.99, a P/E/G ratio of 2.79 and a beta of 0.22. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.44.

Read Our Latest Research Report on JNJ

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

ABBV stock traded up $2.65 during trading on Friday, reaching $286.19. The stock had a trading volume of 8,754,855 shares, compared to its average volume of 5,219,851. The firm has a market cap of $505.88 billion, a PE ratio of 49.26, a PEG ratio of 1.34 and a beta of 0.20. The stock's 50 day moving average is $278.98 and its two-hundred day moving average is $242.55. AbbVie has a 52 week low of $190.75 and a 52 week high of $302.93.

Read Our Latest Research Report on ABBV

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

MRK traded up $0.75 during trading on Friday, hitting $133.56. The company's stock had a trading volume of 15,606,219 shares, compared to its average volume of 9,559,102. The business's 50 day simple moving average is $145.28 and its 200-day simple moving average is $129.29. The firm has a market cap of $329.26 billion, a PE ratio of 137.69, a P/E/G ratio of 6.62 and a beta of 0.13. Merck & Co., Inc. has a one year low of $95.36 and a one year high of $156.92. The company has a quick ratio of 1.14, a current ratio of 1.35 and a debt-to-equity ratio of 1.11.

Read Our Latest Research Report on MRK

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

NASDAQ GILD traded down $0.20 on Friday, hitting $166.33. 7,554,884 shares of the company traded hands, compared to its average volume of 6,456,805. The business's 50 day moving average price is $157.26 and its 200-day moving average price is $142.46. Gilead Sciences has a 52-week low of $116.88 and a 52-week high of $176.58. The company has a current ratio of 1.38, a quick ratio of 1.22 and a debt-to-equity ratio of 1.84. The company has a market capitalization of $206.30 billion, a price-to-earnings ratio of -52.64 and a beta of 0.35.

Read Our Latest Research Report on GILD

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Shares of NYSE:PFE traded down $0.13 during mid-day trading on Friday, reaching $27.41. 38,282,328 shares of the company traded hands, compared to its average volume of 36,186,520. The company's 50 day moving average price is $28.82 and its 200-day moving average price is $27.03. The firm has a market cap of $156.25 billion, a PE ratio of 39.16, a PEG ratio of 1.90 and a beta of 0.31. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.42 and a quick ratio of 1.10. Pfizer has a 52 week low of $23.62 and a 52 week high of $31.44.

Read Our Latest Research Report on PFE

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

NYSE MCK traded up $7.15 on Friday, reaching $1,069.31. 869,451 shares of the stock were exchanged, compared to its average volume of 719,145. McKesson has a one year low of $723.68 and a one year high of $1,121.50. The company's 50-day simple moving average is $974.65 and its two-hundred day simple moving average is $880.71. The firm has a market capitalization of $123.46 billion, a PE ratio of 27.50, a PEG ratio of 1.87 and a beta of 0.27.

Read Our Latest Research Report on MCK

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eli Lilly and Company Right Now?

Before you consider Eli Lilly and Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.

While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines